Wang, Di
Mao, Xia
Que, Yimei
Xu, Menglei
Cheng, Yuhang
Huang, Liang http://orcid.org/0000-0002-8370-3232
Wang, Jue
Xiao, Yi http://orcid.org/0000-0001-7274-6774
Wang, Wen http://orcid.org/0000-0003-3215-3020
Hu, Guang
Zhang, Shangkun
Zhang, Tongcun
Li, Chunrui http://orcid.org/0000-0001-5134-7133
Zhou, Jianfeng http://orcid.org/0000-0002-1332-9230
Article History
Received: 29 June 2021
Revised: 2 October 2021
Accepted: 4 October 2021
First Online: 18 October 2021
Competing interests
: G.H. and J.Z. are among inventors of patent applications related to the CT103A. W.W. and G.H. are employees of Nanjing IASO Therapeutics Ltd. and held interests in the company. J.Z. is a nonpaid member of the Scientific and Medical Advisory Board of Nanjing IASO Therapeutics Ltd. S.Z. and T.Z. are employees of Wuhan Bio‐Raid Biotechnology Co., Ltd. and held interests in the company. All other authors declare no competing interests.